ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 115.00
-5.40 (-4.49%)
At close: Jan 2, 2026
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 639.00K EUR in the quarter ending September 30, 2025, a decrease of -88.61%. This brings the company's revenue in the last twelve months to 5.31M, down -42.89% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.
Revenue (ttm)
5.31M
Revenue Growth
-42.89%
P/S Ratio
1,685.27
Revenue / Employee
79.27K
Employees
69
Market Cap
8.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
| Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
| Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
| Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
| Dec 31, 2020 | 14.00K | 21.00K | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| Ramsay Générale de Santé | 5.24B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
ABIVAX Société Anonyme News
- 10 days ago - Unpacking the Latest Options Trading Trends in Abivax - Benzinga
- 10 days ago - Abivax: Here's Why Eli Lilly Could Want Its Oral Ulcerative Colitis Therapy - Seeking Alpha
- 11 days ago - Why Abivax Stock Was on Fire Today - The Motley Fool
- 11 days ago - Abivax is the top performing biotechnology stock YTD - Seeking Alpha
- 11 days ago - Abivax (ABVX) Rises Significantly with 17.5% Gain - GuruFocus
- 11 days ago - Abivax (ABVX) Stock Jumps Over 16% in Market Boost - GuruFocus
- 15 days ago - Abivax (ABVX) Joins Nasdaq Biotechnology Index - GuruFocus
- 15 days ago - Abivax to be Added to Nasdaq Biotechnology Index - GlobeNewsWire